Jon joined EyeBio as Finance Director in March 2023, bringing over 15 years of experience across R&D, finance, and investment in the biotech sector.
Originally trained as a medicinal chemist, Jon worked as a Senior Scientist in Drug Discovery at Evotec, generating multiple patents and contributing to a variety of publications in the field of inflammation. In 2011 Jon moved into a finance role and qualified as a chartered accountant in PwC’s financial services division. He has since worked in the biotech venture capital sector, joining SV Health Investors in 2015. Jon performed a range of roles at SV, supporting creation of, and serving as Head of Finance for, the £250m Dementia Discovery Fund. During this time Jon increasingly performed supporting and non-executive roles for several early-stage UK biotechs, and joined Enara Bio full-time as Finance Director in 2020.
Jon holds an MSci in Biochemistry and Biological Chemistry from the University of Nottingham, a Ph.D. in Medicinal Chemistry from UCL, and is a Chartered Accountant (ACA),
